However, most of the current knowledge concerning PHB proteins in cancers has been gleaned from studies with prohibitin 1 (PHB1), while studies on the effects of PHB2 have been limited to date, especially in NSCLC 34, 37-40. Here, PHB2 is linked to non-small cell lung carcinoma.